SCHEMBL17479350

SCHEMBL17479350

O=C(Nc1ncnc2c([C@@H]3O[C@H](COCc4ccccc4)[C@@H](OCc4ccccc4)[C@H]3F)csc12)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 1/20 0.38
▸ NT5E P21589 1/20 0.38
▸ BCHE P06276 1/20 0.37
▸ TACR2 P21452 3/20 0.36
▸ PTPN1 P18031 6/20 0.35
▸ CDC25B P30305 5/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ RPS6KB1 P23443 2/20 0.34
▸ PDPK1 O15530 1/20 0.34
▸ PTPN2 P17706 3/20 0.34
▸ PTPN6 P29350 2/20 0.34
▸ PTPN11 Q06124 2/20 0.34
▸ TP53 P04637 1/20 0.33
▸ MDM2 Q00987 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ P2RY12 Q9H244 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17468596 0.86 PDE4A (0.35) RPS6KB1TP53AURKA
SCHEMBL19644579 0.82 PDE2A (0.51) PDE2ANT5EBCHETACR2PTPN1
SCHEMBL17453485 0.80 PDE2A (0.41) PDE2ANT5EBCHETACR2PTPN1
SCHEMBL29788347 0.80 PDE2A (0.41) PDE2ANT5EBCHETACR2PTPN1
SCHEMBL17465396 0.79 LGALS9 (0.38) PDPK1
SCHEMBL17465432 0.78 BRD4 (0.35) RPS6KB1PDPK1AURKA
SCHEMBL17465397 0.78 SMN1; SMN2 (0.35) RPS6KB1PDPK1AURKA
SCHEMBL21837294 0.77 PRMT6 (0.33) PDPK1
SCHEMBL17465401 0.75 BRD4 (0.35) RPS6KB1PDPK1AURKA
SCHEMBL21837303 0.75 GPR119 (0.32) RPS6KB1PDPK1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4023650-A1 4'-SUBSTITUTED-FURO[3,2-D]PYRIMIDINE AND -PYRROLO[3,2- D]PYRIMIDINE DERIVATIVES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS Gilead Sciences, Inc. (US) 2022-07-06 — — EP disclosed
EP-3693367-B1 THIENO [3,2-D]PYRIMIDINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS GILEAD SCIENCES INC (US) 2022-02-16 — — EP disclosed
EP-3174870-B1 THIENO [3,2-D]PYRIMIDINES, FURO [3,2,D]PYRIMIDINES AND PYRROLO [3,2-D]PYRIMIDINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS GILEAD SCIENCES INC (US) 2020-04-15 — — EP disclosed
EP-3174870-A1 THIENO [3,2-D]PYRIMIDINE, FURO [3,2,D]PYRIMIDINE, AND PYRROLO [3,2-D]PYRIMIDINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS Gilead Sciences, Inc. (US) 2017-06-07 — — EP disclosed
WO-2016018697-A1 THIENO [3,2-D] PYRIMIDINE, FURO [3,2,D] PYRIMIDINE, AND PYRROLO [3,2-D] PYRIMIDINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS GILEAD SCIENCES, INC. (US) 2016-02-04 — — WO disclosed
Send feedback